Register      Login

VOLUME 3 , ISSUE 1 ( January-March, 2024 ) > List of Articles


To Save Babies, We Need a Team – Let's Build One!

Akhil Maheshwari, Kei Lui, Mario Motta

Citation Information :

DOI: 10.5005/newborn-3-1-iv

License: CC BY-NC 4.0

Published Online: 26-03-2024

Copyright Statement:  Copyright © 2024; The Author(s).


PDF Share
  1. World-Health-Organization. Newborn mortality 2024 [Available from:
  2. Barfield WD. Standard terminology for fetal, infant, and perinatal deaths. Pediatrics. 2016;137(5):e20160551. doi: 10.1542/peds.2016-0551.
  3. Mengistu TS, Schreiber V, Flatley C, Fox J, Kumar S. Factors associated with increased risk of early severe neonatal morbidity in late preterm and early term infants. J Clin Med. 2021;10(6). doi: 10.3390/jcm10061319.
  4. Global-newborn-society. Every baby counts: each time we lose an infant, we lose an entire life and its potential 2024 [Available from:
  5. Barbosa VM. Teamwork in the neonatal intensive care unit. Phys Occup Ther Pediatr. 2013;33(1):5–26. doi: 10.3109/01942638.2012.729556.
  6. Office-of-Disease-Prevention-and-Health-Promotion. Infants 2024 [Available from:
  7. National-Center-for-Health-Statistics. Births and Natality 2024 [Available from:
  8. Doody O, Bailey ME. Setting a research question, aim and objective. Nurse Res. 2016;23(4):19–23. doi: 10.7748/nr.23.4.19.s5.
  9. Hurn J, Kneebone I, Cropley M. Goal setting as an outcome measure: A systematic review. Clin Rehabil. 2006;20(9):756–772. doi: 10.1177/0269215506070793.
  10. Madewell ZJ, Whitney CG, Velaphi S, Mutevedzi P, Mahtab S, Madhi SA, et al. Prioritizing Health Care Strategies to Reduce Childhood Mortality. JAMA Netw Open. 2022;5(10):e2237689. doi: 10.1001/jamanetworkopen.2022.37689.
  11. Chen A, Oster E, Williams H. Why is infant mortality higher in the United States than in Europe? Am Econ J Econ Policy. 2016;8(2):89–124. doi: 10.1257/pol.20140224.
  12. Eckhoff DO, Weiss J. Goal setting: A concept analysis. Nurs Forum. 2020;55(2):275–281. doi: 10.1111/nuf.12426.
  13. Bell EA, Rufrano GA, Traylor AM, Ohning BL, Salas E. Enhancing team success in the neonatal intensive care unit: challenges and opportunities for fluid teams. Front Psychol. 2023;14:1284606. doi: 10.3389/fpsyg.2023.1284606.
  14. Morley L, Cashell A. Collaboration in Health Care. J Med Imaging Radiat Sci. 2017;48(2):207–216. doi: 10.1016/j.jmir.2017.02.071.
  15. Bedwell WL. Adaptive Team Performance: The influence of membership fluidity on shared team cognition. Front Psychol. 2019;10:2266. doi: 10.3389/fpsyg.2019.02266.
  16. Alderwick H, Hutchings A, Briggs A, Mays N. The impacts of collaboration between local health care and non-health care organizations and factors shaping how they work: a systematic review of reviews. BMC Public Health. 2021;21(1):753. doi: 10.1186/s12889-021-10630-1.
  17. Pina IL, Cohen PD, Larson DB, Marion LN, Sills MR, Solberg LI, et al. A framework for describing health care delivery organizations and systems. Am J Public Health. 2015;105(4):670–679. doi: 10.2105/AJPH.2014.301926.
  18. World-Health-Organization. WHO global strategy on people-centred and integrated health services 2024 [Available from: https://www.afro.who. int/sites/default/files/2017-07/who-global-strategy-on-pcihs-main-document_final.pdf.
  19. Lawn JE, Ehret DEY, Mutema T, Stevenson A, Walker K, Storari L, et al. Every Newborn Counts, Everywhere: Statement from the 2023 Joint European Neonatal Societies' (jENS) Congress. newborn (Clarksville). 2024;3(1):1–2. doi: 10.5005/jp-journals-11002-0087.
  20. United-Nations-Childrens-Emergency-Fund. A Neglected Tragedy: The global burden of stillbirths 2024 [Available from:
  21. United-Nations-Department-of-Economic-and-Social-Affairs. Sustainable Development: The 17 Goals 2024 [Available from:
  22. United-Nations-Children's-Emergency-Fund. Child survival and the SDGs 2024 [Available from: sdgs/.
  23. United-Nations. World Down Syndrome Day 21 March 2024 [Available from:
  24. Down-Syndrome-International. Lots of Socks campaign 2024 [Available from:
  25. Schneider DJ. The patent ductus arteriosus in term infants, children, and adults. Semin Perinatol. 2012;36(2):146–153. doi: 10.1053/j.semperi.2011.09.025.
  26. Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, et al. Down syndrome. Nat Rev Dis Primers. 2020;6(1):9. doi: 10.1038/s41572- 019-0143-7.
  27. Graupe MH, Naylor CS, Greene NH, Carlson DE, Platt L. Trisomy 21. Second-trimester ultrasound. Clin Perinatol. 2001;28(2):303–319. doi: 10.1016/s0095-5108(05)70085-3.
  28. Devlin L, Morrison PJ. Accuracy of the clinical diagnosis of Down syndrome. Ulster Med J. 2004;73(1):4–12. PMID: 15244118.
  29. Berisha SZ, Shetty S, Prior TW, Mitchell AL. Cytogenetic and molecular diagnostic testing associated with prenatal and postnatal birth defects. Birth Defects Res. 2020;112(4):293–306. doi: 10.1002/bdr2.1648.
  30. Biesecker LG, Spinner NB. A genomic view of mosaicism and human disease. Nat Rev Genet. 2013;14(5):307–320. doi: 10.1038/nrg3424.
  31. Papavassiliou P, York TP, Gursoy N, Hill G, Nicely LV, Sundaram U, et al. The phenotype of persons having mosaicism for trisomy 21/Down syndrome reflects the percentage of trisomic cells present in different tissues. Am J Med Genet A. 2009;149A(4):573–583. doi: 10.1002/ajmg.a.32729.
  32. Orr B, Godek KM, Compton D. Aneuploidy. Curr Biol. 2015;25(13):R538–42. doi: 10.1016/j.cub.2015.05.010.
  33. Mohan S, Badami K, Kumar P, Shilpa YD, Hemalata BC, Tumbadi K. Prediction of retinopathy of prematurity in single and twin babies: The predictive accuracy of WINROP. newborn (Clarksville). 2024;3(1):3–7. doi: 10.5005/jp-journals-11002-0084.
  34. Sahota R, Singh V, Parveen H, Kaur N, Upreti N, Mahindre A, et al. Comparison of transcutaneous bilirubin with total serum bilirubin levels before, during, and post-phototherapy in preterm and term newborns in Uttarakhand, India. newborn (Clarksville). 2024;3(1):8–12. doi: 10.5005/jp-journals-11002-0086.
  35. Hameed NN, Khaleel MM, Saugstad OD. Timely respiratory support can improve clinical outcomes of premature infants in a country with limited medical resources due to chronic conflicts. newborn (Clarksville). 2024;3(1):13–18. doi: 10.5005/jp-journals-11002-0088.
  36. Guay JM, Carvi D, Raines DA, Luce WA. Care of the neonate on nasal continuous positive airway pressure: A Bedside Guide. Neonatal Netw. 2018;37(1):24–32. doi: 10.1891/0730-0832.37.1.24.
  37. Maheshwari A, Mantry H, Bagga N, Frydrysiak-Brzozowska A, Badarch J, Rahman MM. Milk Fat Globules: 2024 Updates. newborn (Clarksville). 2024;3:19–37. doi. 10.5005/jp-journals-11002-0085.
  38. Maheshwari A. Fats in Human Milk: 2022 Updates on Chemical Composition. newborn (Clarksville). 2022;1(4):384–396. doi: 10.5005/jp-journals-11002-0050.
  39. Ross MG, Kavasery MP, Cervantes MK, Han G, Horta B, Coca KP, et al. High-fat, high-calorie breast milk in women with overweight or obesity and its association with maternal serum insulin concentration and triglycerides levels. Children (Basel). 2024;11(2). doi: 10.3390/children11020141.
  40. Thum C, Roy NC, Everett DW, McNabb WC. Variation in milk fat globule size and composition: A source of bioactives for human health. Crit Rev Food Sci Nutr. 2023;63(1):87–113. doi: 10.1080/10408398.2021.1944049.
  41. Manoni M, Di Lorenzo C, Ottoboni M, Tretola M, Pinotti L. Comparative proteomics of milk fat globule membrane (mfgm) proteome across species and lactation stages and the potentials of mfgm fractions in infant formula preparation. Foods. 2020;9(9). doi: 10.3390/foods9091251.
  42. Raza GS, Herzig KH, Leppaluoto J. Invited review: Milk fat globule membrane–A possible panacea for neurodevelopment, infections, cardiometabolic diseases, and frailty. J Dairy Sci. 2021;104(7):7345–7363. doi: 10.3168/jds.2020-19649.
  43. Davenport P, Sola-Visner M. Hemostatic challenges in neonates. Front Pediatr. 2021;9:627715. doi: 10.3389/fped.2021.627715.
  44. Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J Anaesth. 2014;58(5):515–523. doi: 10.4103/0019-5049.144643.
  45. Mehic D, Colling M, Pabinger I, Gebhart J. Natural anticoagulants: A missing link in mild to moderate bleeding tendencies. Haemophilia. 2021;27(5):701–709. doi: 10.1111/hae.14356.
  46. Strauss T, Elisha N, Ravid B, Rosenberg N, Lubetsky A, Levy-Mendelovich S, et al. Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates. Blood Cells Mol Dis. 2017;67:14–17. doi: 10.1016/j.bcmd.2016.12.013.
  47. Buyukinan M, Yilmaz D, Yalaz M, Koroglu OA, Akisu M, Kavakli K, et al. Long-term ongoing coagulopathy in premature infants with respiratory distress syndrome. Clin Appl Thromb Hemost. 2013;19(5):535–540. doi: 10.1177/1076029612444003.
  48. Hartmann J, Hermelin D, Levy JH. Viscoelastic testing: an illustrated review of technology and clinical applications. Res Pract Thromb Haemost. 2023;7(1):100031. doi: 10.1016/j.rpth.2022.100031.
  49. Guaragni B, Motta M. Hemostasis assessment in neonates: Evaluation of viscoelastic properties of blood clots. newborn (Clarksville). 2024;3(1): 38–44. doi: 10.5005/jp-journals-11002-0089.
  50. Maheshwari A, Huisman TAGM. Holoprosencephaly. newborn (Clarksville). 2024;3(1):45–60. doi: 10.5005/jp-journals-11002-0083.
  51. Dubourg C, Bendavid C, Pasquier L, Henry C, Odent S, David V. Holoprosencephaly. Orphanet J Rare Dis. 2007;2:8. doi: 10.1186/1750-1172-2-8.
  52. Raam MS, Solomon BD, Muenke M. Holoprosencephaly: a guide to diagnosis and clinical management. Indian Pediatr. 2011;48(6):457–466. doi: 10.1007/s13312-011-0078-x.
  53. Bullen PJ, Rankin JM, Robson SC. Investigation of the epidemiology and prenatal diagnosis of holoprosencephaly in the North of England. Am J Obstet Gynecol. 2001;184(6):1256–1262. doi: 10.1067/mob.2001.111071.
  54. Yi L, Liu Z, Deng C, Li X, Wang K, Deng K, et al. Epidemiological characteristics of holoprosencephaly in China, 2007-2014: A retrospective study based on the national birth defects surveillance system. PLoS One. 2019;14(6):e0217835. doi: 10.1371/journal.pone.0217835.
  55. Malta M, AlMutiri R, Martin CS, Srour M. Holoprosencephaly: Review of Embryology, Clinical Phenotypes, Etiology and Management. Children (Basel). 2023;10(4). doi: 10.3390/children10040647.
  56. Geng X, Oliver G. Pathogenesis of holoprosencephaly. J Clin Invest. 2009;119(6):1403–1413. doi: 10.1172/JCI38937.
  57. Kauvar EF, Muenke M. Holoprosencephaly: recommendations for diagnosis and management. Curr Opin Pediatr. 2010;22(6):687–695. doi: 10.1097/MOP.0b013e32833f56d5.
  58. Hadley DW, Kruszka P, Muenke M. Challenging issues arising in counseling families experiencing holoprosencephaly. Am J Med Genet C Semin Med Genet. 2018;178(2):238–245. doi: 10.1002/ajmg.c.31627.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.